HK1180311A1 - 抗病毒雙趺喃衍生物用作 蛋白酶抑制劑和其中間產物 - Google Patents

抗病毒雙趺喃衍生物用作 蛋白酶抑制劑和其中間產物

Info

Publication number
HK1180311A1
HK1180311A1 HK13107502.1A HK13107502A HK1180311A1 HK 1180311 A1 HK1180311 A1 HK 1180311A1 HK 13107502 A HK13107502 A HK 13107502A HK 1180311 A1 HK1180311 A1 HK 1180311A1
Authority
HK
Hong Kong
Prior art keywords
hiv
bisfuran
antiviral
intermediates
derivative
Prior art date
Application number
HK13107502.1A
Other languages
English (en)
Inventor
R Crawford Kenneth
D Dowdy Eric
Gutierrez Arnold
P Polniaszek Richard
Hung Chiu Yu Richard
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of HK1180311A1 publication Critical patent/HK1180311A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/38—Amides of thiocarboxylic acids
    • C07C327/40—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C327/42—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4075—Esters with hydroxyalkyl compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4084—Esters with hydroxyaryl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK13107502.1A 2006-03-29 2009-06-10 抗病毒雙趺喃衍生物用作 蛋白酶抑制劑和其中間產物 HK1180311A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78712606P 2006-03-29 2006-03-29

Publications (1)

Publication Number Publication Date
HK1180311A1 true HK1180311A1 (zh) 2013-10-18

Family

ID=38323963

Family Applications (2)

Application Number Title Priority Date Filing Date
HK09105198.0A HK1126756A1 (en) 2006-03-29 2009-06-10 Process for preparation of hiv protease inhibitors
HK13107502.1A HK1180311A1 (zh) 2006-03-29 2009-06-10 抗病毒雙趺喃衍生物用作 蛋白酶抑制劑和其中間產物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK09105198.0A HK1126756A1 (en) 2006-03-29 2009-06-10 Process for preparation of hiv protease inhibitors

Country Status (25)

Country Link
US (4) US8173623B2 (zh)
EP (2) EP1999133B1 (zh)
JP (2) JP5430395B2 (zh)
KR (2) KR101429300B1 (zh)
CN (2) CN101448838B (zh)
AP (2) AP2757A (zh)
AU (1) AU2007245194B2 (zh)
BR (1) BRPI0710199A2 (zh)
CA (1) CA2647316C (zh)
DK (1) DK1999133T3 (zh)
EA (2) EA016140B1 (zh)
ES (2) ES2430557T3 (zh)
HK (2) HK1126756A1 (zh)
HR (2) HRP20080554B1 (zh)
IL (2) IL194122A (zh)
MX (1) MX2008012398A (zh)
NO (2) NO342102B1 (zh)
NZ (2) NZ571302A (zh)
PL (1) PL1999133T3 (zh)
PT (1) PT1999133E (zh)
SG (1) SG170794A1 (zh)
SI (1) SI1999133T1 (zh)
UA (1) UA97241C2 (zh)
WO (1) WO2007126812A2 (zh)
ZA (1) ZA200808046B (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8921415B2 (en) 2009-01-29 2014-12-30 Mapi Pharma Ltd. Polymorphs of darunavir
ES2516916T3 (es) 2010-01-28 2014-10-31 Mapi Pharma Limited Procedimiento para la preparación de darunavir e intermedios de darunavir
CN102190638A (zh) * 2010-03-16 2011-09-21 中国科学院上海药物研究所 联芳基醇二胺类化合物、其药物组合物、制备方法及应用
CN102584748B (zh) * 2011-01-13 2015-02-11 浙江九洲药业股份有限公司 夫沙那韦中间体的制备方法
WO2012147104A1 (en) * 2011-04-26 2012-11-01 Mylan Laboratories Ltd Novel process for the preparation of etravirine
KR20200090975A (ko) * 2011-10-07 2020-07-29 길리애드 사이언시즈, 인코포레이티드 항-바이러스 뉴클레오티드 유사체의 제조 방법
EP2634180A1 (en) 2012-03-01 2013-09-04 Lonza Ltd. Enzymatic process for the preparation of butyrolactones
CN103664976B (zh) * 2013-12-12 2015-11-04 惠州市莱佛士制药技术有限公司 一种顺式六氢呋喃并[2,3-b]呋喃-3-醇的制备方法
EP3104712B1 (en) * 2014-02-12 2020-05-06 Firmenich Incorporated Improved process for the synthesis of substituted 1-benzyl-3-(1-(isoxazol-4-ylmethyl)-1h-pyrazol-4-yl)imidazolidine-2,4-diones
KR20230130175A (ko) 2014-12-26 2023-09-11 에모리 유니버시티 Ｎ4-하이드록시시티딘, 이와 관련된 유도체 및 이의 항 바이러스적 용도
JP6435907B2 (ja) * 2015-02-16 2018-12-12 住友化学株式会社 ヘキサヒドロフロフラノール誘導体の製造方法
CN108610227B (zh) * 2016-12-10 2021-02-09 中国科学院大连化学物理研究所 一种制备双环芳香化合物的方法
AU2018378832B9 (en) 2017-12-07 2021-05-27 Emory University N4-hydroxycytidine and derivatives and anti-viral uses related thereto
UA128041C2 (uk) 2019-01-25 2024-03-20 Браун Юніверсіті Спосіб лікування пов'язаного з віком запалення у пацієнта

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994026749A1 (en) * 1993-05-14 1994-11-24 Merck & Co., Inc. Hiv protease inhibitors
AU1369001A (en) * 1995-12-13 2001-03-22 Abbott Laboratories Retroviral protease inhibiting compounds
ATE401298T1 (de) 1999-12-23 2008-08-15 Ampac Fine Chemicals Llc Verbessertes verfahren zur herstellung von 2s,3s- n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)- - nitrobenzenesulfonylamid hydrochlorid und anderen derivaten von 2-hydroxy-1,3-diamin
WO2002067239A2 (en) * 2000-10-24 2002-08-29 Glaxo Group Limited Process for preparing intermediates of hiv protease inhibitors
JP2004536546A (ja) 2001-07-20 2004-12-02 コーニンクレッカ　フィリップス　エレクトロニクス　エヌ　ヴィ 発振回路、斯かる発振回路を有するコンバータ、及び斯かるコンバータを有するプレコンディショニング装置
US7462608B2 (en) * 2002-04-26 2008-12-09 Gilead Sciences, Inc. Non nucleoside reverse transcriptase inhibitors
US20050239054A1 (en) * 2002-04-26 2005-10-27 Arimilli Murty N Method and compositions for identifying anti-HIV therapeutic compounds
US7273715B2 (en) * 2003-10-24 2007-09-25 Gilead Sciences, Inc. Methods and compositions for identifying therapeutic compounds with GS-9005 ester hydrolase A

Also Published As

Publication number Publication date
KR20080108322A (ko) 2008-12-12
AP2008004641A0 (en) 2008-10-31
CA2647316C (en) 2013-05-28
CA2647316A1 (en) 2007-11-08
EP2570416A1 (en) 2013-03-20
CN101448838B (zh) 2012-07-04
KR101395377B1 (ko) 2014-05-14
PT1999133E (pt) 2013-10-16
US8173623B2 (en) 2012-05-08
UA97241C2 (uk) 2012-01-25
HRP20080554B1 (hr) 2014-11-21
KR20140021047A (ko) 2014-02-19
NO20084547L (no) 2008-12-22
DK1999133T3 (da) 2013-11-25
ES2430557T3 (es) 2013-11-21
ES2572001T3 (es) 2016-05-27
NZ596074A (en) 2013-03-28
CN102516259B (zh) 2014-12-10
BRPI0710199A2 (pt) 2012-03-06
US20080004242A1 (en) 2008-01-03
NO20180086A1 (no) 2008-12-22
SI1999133T1 (sl) 2013-10-30
HRP20140626A2 (hr) 2014-11-07
WO2007126812A2 (en) 2007-11-08
CN101448838A (zh) 2009-06-03
HRP20080554A2 (en) 2009-02-28
NO342102B1 (no) 2018-03-26
AU2007245194A1 (en) 2007-11-08
US20110065631A1 (en) 2011-03-17
MX2008012398A (es) 2008-12-17
CN102516259A (zh) 2012-06-27
US20120258935A1 (en) 2012-10-11
IL194122A (en) 2016-08-31
AP2013006690A0 (en) 2013-01-31
WO2007126812A3 (en) 2007-12-21
US8431745B2 (en) 2013-04-30
IL225167A (en) 2016-03-31
NZ571302A (en) 2011-11-25
PL1999133T3 (pl) 2014-01-31
JP2013082717A (ja) 2013-05-09
JP5430395B2 (ja) 2014-02-26
EA020088B1 (ru) 2014-08-29
EA201100994A1 (ru) 2012-03-30
ZA200808046B (en) 2009-06-24
AP2757A (en) 2013-09-30
EP1999133A2 (en) 2008-12-10
HK1126756A1 (en) 2009-09-11
JP2009531441A (ja) 2009-09-03
US20130172295A1 (en) 2013-07-04
NO342965B1 (no) 2018-09-10
EP1999133B1 (en) 2013-08-21
SG170794A1 (en) 2011-05-30
EP2570416B1 (en) 2016-03-16
KR101429300B1 (ko) 2014-08-11
EA016140B1 (ru) 2012-02-28
EA200802074A1 (ru) 2009-02-27
AU2007245194B2 (en) 2013-03-14

Similar Documents

Publication Publication Date Title
HK1180311A1 (zh) 抗病毒雙趺喃衍生物用作 蛋白酶抑制劑和其中間產物
HK1210142A1 (zh) 蛋白酶抑制劑和其用途
HK1210141A1 (zh) 蛋白酶抑制劑和其用途
IL194434A0 (en) Hcv/hiv inhibitors and their uses
HK1129679A1 (zh) 作為 抑制劑的對映體純的磷酸吲哚
IL179056A0 (en) An hiv protease inhibitor
TWI365876B (en) Prodrugs of hiv protease inhibitors
DK2023902T3 (da) DPP-IV-inhibitor-formuleringer
HK1154247A1 (zh) 核苷類抑制劑
HK1127351A1 (zh) 抗病毒蛋白酶抑制劑
HK1136576A1 (en) Azapeptide derivatives as hiv protease inhibitors
EP2099789A4 (en) INHIBITORS OF HIV REPLICATION
IL183850A0 (en) Hiv protease inhibitors
EP1855672A4 (en) HIV PROTEASE INHIBITORS
EP2064177A4 (en) PROTEASE INHIBITORS
ZA200804607B (en) Substituted aminophenylsulfonamide compounds as HIV protease inhibitor
ZA200900907B (en) Pyrimidine derivative as P13K inhibitor and use thereof
EP2134336A4 (en) HIV PROTEASE INHIBITORS DERIVED FROM BENZOFURAN
ZA200706305B (en) HIV protease inhibitors
ZA200804610B (en) Aminophenylsulfonamide derivatives as HIV protease inhibitor
EP1728515A4 (en) INHIBITOR OF INFLUENZA VIRUS INFECTION
ZA200808645B (en) Deuterated hepatitis C protease inhibitors
ZA200808226B (en) HCV/HIV inhibitors and their uses
TWI316060B (en) Neuraminidase inhibitor
ZA200702390B (en) S-triazolyl α-mercaptoacetanildes as inhibitors of HIV reverse transciptase